Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|April 23, 2010
Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferationSabrina Taliani, Concettina La Motta, Laura Mugnaini, et al.
Journal of Medicinal Chemistry|July 16, 2015
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamidesElisabetta Barresi, Agostino Bruno, Sabrina Taliani, et al.
Journal of Medicinal Chemistry|April 17, 2010
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptorEnrica Calleri, Stefania Ceruti, Gloria Cristalli, et al.
Journal of Medicinal Chemistry|January 20, 2012
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonistsSabrina Taliani, Isabella Pugliesi, Elisabetta Barresi, et al.
Molecular Neurobiology|March 4, 2019
Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's DiseaseFilippo Baldacci, Simona Daniele, Rebecca Piccarducci, et al.
Journal of Medicinal Chemistry|September 19, 2017
Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological ActivityMariateresa Giustiniano, Simona Daniele, Sveva Pelliccia, et al.
European Journal of Medicinal Chemistry|June 15, 2025
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's diseaseAlan Santini, Elisa Tassinari, Alessandra Altomare, et al.
Journal of Medicinal Chemistry|July 15, 2011
New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compoundsMaurizio Anzini, Salvatore Valenti, Carlo Braile, et al.
European Journal of Pharmacology|February 13, 2021
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiformeSimona Daniele, Valeria La Pietra, Rebecca Piccarducci, et al.
ACS Chemical Neuroscience|May 15, 2024
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's DiseaseAlan Santini, Elisa Tassinari, Eleonora Poeta, et al.
Pageof 13